Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Silexion Therapeutics Ltd. logo

Silexion Therapeutics Ltd. (SLXN) Stock Ticker

NASDAQ: SLXN · Healthcare · Biotechnology
$0.2484-4.57%
USD · as of 2026-09-29 · market cap $104,079
Open SLXN in TickrDownload for iPhone

SLXN right now

Down 69% in the last month.
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full SLXN picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on SLXN
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Silexion Therapeutics Ltd.

Silexion Therapeutics LTD is a biopharmaceutical company specializing in the discovery and advancement of RNA interference (RNAi)-based cancer therapies and their associated delivery systems, with a focus on treating aggressive solid tumors. The company's strategy for addressing these tumors relies on its proprietary LODER delivery platform. Its product pipeline features several key candidates: SiG12D-LODER, which has progressed through both preclinical studies and an open-label Phase I clinical trial for pancreatic cancer; Prostate-LODER, currently undergoing preclinical evaluation for prostate cancer; and GBM-LODER, also in preclinical development, targeting Glioblastoma Multiforme, a highly malignant primary brain tumor. Founded in 2008, Silexion Therapeutics is headquartered in Jerusalem, Israel.

SLXN stock facts

Ticker symbolSLXN
ExchangeNASDAQ Global Market
SectorHealthcare
IndustryBiotechnology
Market cap$104,079
CEOIlan Hadar
Employees14
HeadquartersJerusalem, TA, IL
IPO date2024-08-16
Websitesilexion.com

What you can see for SLXN on Tickr

Live SLXN price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the SLXN report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Silexion Therapeutics Ltd.?

The ticker symbol for Silexion Therapeutics Ltd. is SLXN, listed on the NASDAQ Global Market.

What is SLXN?

Silexion Therapeutics LTD is a biopharmaceutical company specializing in the discovery and advancement of RNA interference (RNAi)-based cancer therapies and their associated delivery systems, with a focus on treating aggressive solid tumors. The company's strategy for addressing these tumors relies on its proprietary LODER delivery platform. Its product pipeline features several key candidates:…

HomeExploreMarketLists
All pages